Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C1762617 (weakness)
 37,932 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In a randomized double-blind parallel group study conducted in three centres the hypotensive activity of piretanide 6 mg b.i.d. was compared with that of hydrochlorothiazide (HCT) 25 mg b.i.d. and HCT 50 mg b.i.d. Ninety-three patients entered the study and sixty-one completed a 16-week trial period. All three treatments produced a significant reduction in supine diastolic and systolic blood pressure after only 2 weeks of active treatment and this was maintained for the duration of the study. The mean maximal reduction in supine diastolic blood pressure was 18% in the piretanide group, 18.8% in the HCT 25 mg b.i.d. group, and 20% in the HCT 50 mg b.i.d. group. The corresponding figures for the percentage of patients attaining a supine diastolic pressure below 95 mm Hg were 83%, 62% and 89%. There were no significant differences between the three groups. Side-effects were generally mild and transient, except for polyuria which was noted in all three groups but more commonly in the piretanide group. Two patients were withdrawn because of side-effects: one patient in the high dose HCT group developed severe postural symptoms; and one patient in the low dose HCT group was withdrawn because of restlessness, nausea, weakness, dizziness and somnolence. All three treatments caused a significant increase in serum uric acid concentrations. Four patients in each of the HCT groups developed hypokalaemia, but no patients in the piretanide group did so.
 ...
PMID:A double-blind multicentre study of piretanide and hydrochlorothiazide in patients with essential hypertension. 637 42

Twenty patients complaining of excessive daytime somnolence (EDS) secondary to significant head trauma were studied objectively. Several polygraphic recording protocols were performed over the 12-year study period. Eighteen of the 20 patients were objectively sleepy, 8 of them presented mixed sleep apnea syndrome that fragmented their sleep, 5 patients' sleep-related breathing problems improved over time, 9 patients presented daytime somnolence, and 1 reported abrupt bouts of muscle weakness and had two sleep onset rapid eye movement (REM) periods during daytime testing. Cerebrospinal fluid analysis for specific neurotransmitter metabolites' evaluation, pre- and postprobenecid, did not differentiate posttraumatic EDS patients from narcoleptics or other patients with EDS. Two patients (one with organic brain syndrome, the other depressed) reported subjective sleepiness, not confirmed by objective data. Objective testing in posttraumatic sleepiness is recommended because of the plurality of problems and medicolegal implications.
 ...
PMID:Posttraumatic excessive daytime sleepiness: a review of 20 patients. 668 31

Psychogenic faint (vasovagal syncope) shows no difference with respect to age and frequency of attacks in women and men. A marked increase in frequency is found in earlier ages up to 25. Physical complaints include: blackout, weakness of the limbs, sensation of heat, nausea, palpitations, drowsiness. Mental sensations include: feeling of being overpowered, fear, helplessness, being unable to run away and of relief. Subjective emotional involvement in the situation seems to be decisive for eliciting psychogenic syncope, the subject being no longer able to control the situation from the psychic aspect and allows himself to "fall in to a faint".
 ...
PMID:[Psychosomatics of psychogenic faint (vasovagal syncope) (author's transl)]. 676 22

Eighty-one healthy male soldiers, aged 18-34, were studied for 5 d before and 5 d after an eastward deployment across six time zones to determine the effects of translocation on exercise capacity and performance. Fatigue, weakness, headache, sleepiness, irritability, and other commonly reported symptoms occurred in the majority of subjects. Most, but not all, of the symptoms were diminished or absent by the fifth day following the translocation. Cardiorespiratory function and perception of effort during both submaximal and maximal treadmill exercise were unaffected. Isometric strength of the upper torso, legs, and trunk extensor muscles also was not changed. Dynamic strength and endurance of elbow flexors declined significantly. Dynamic knee extensor strength and endurance scores exhibited a progressive decrement prior to translocation and were inconsistent suggesting that the stress of repetitive testing outweighed any jet-lag effects on performance capacity. Performance times for a 270 m sprint were increased for the first 4 d following translocation as were times for a 2.8 km run on the second and third days and for a 110 m lift and carry on the third day after deployment. Times for a 6.5 m rope climb did not change. These findings indicate that certain symptoms and physiological capacities are affected as a result of multiple time zone translocation. However, the specific mechanisms involved, the factors influencing the magnitude of any physiological alterations, and the ultimate impact of these capacity changes on actual physical performance remain to be clarified.
 ...
PMID:Effects of travel across time zones (jet-lag) on exercise capacity and performance. 683 49

A tablet formulation of nifedipine was given to 8 hospitalized hypertensive men, W.H.O. stage I or II, mean age 45 years. After an initial placebo test, nifedipine 20, 40 or 60 mg was given in random order at 72-h intervals, in a single administration crossover study. The placebo and the active drug were given at 8 a.m. Blood pressure and heart rate were measured twice by the same observer, every 20 min from 7 to 8 a.m., and then hourly until 8 p.m., first in recumbency and again after 1 min of standing upright. Plasma nifedipine was assayed in samples taken hourly from 8 a.m. to noon, every 2 h from noon to 8 p.m., and 24 and 48 h after drug administration. All 3 doses significantly lowered blood pressure; the fall during recumbency was significantly larger (-18%) and lasted longer (12 h) after 60 mg than after 20 mg (-11% and 7 h). All 3 doses caused a similar increase in heart rate (+29 to +38%), which reached its maximum after 2 h and lasted for 5 h. The maximum plasma concentration and the area under the plasma concentration--time curve were dose-dependent despite large inter-subject variation. Absorption, bioavailability and elimination were linear between the 20 and 60 mg doses. Plasma nifedipine levels were strongly correlated with the concomitant decrease in mean arterial blood pressure (r = 0.61, p less than 0.001). Four patients experienced mild side effects (headaches, flushes, drowsiness or weakness). This tablet form of nifedipine has a potent antihypertensive action which lasts longer than that of the capsule presentation.
 ...
PMID:Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine. 684 Jan 59

A twin crossover assay of oral zomepirac and intramuscular morphine was completed in 159 cancer patients with postoperative pain. Zomepirac was a surprisingly effective oral analgesic in these patients, 100 mg orally being roughly equivalent to 16 mg intramuscular morphine. Time-effect data indicate that the peak effect for oral zomepirac may occur slightly later than that for morphine but that zomepirac is relatively rapidly effective after oral administration. Side effect occurrence was roughly in the same range for both drugs, with drowsiness, nausea, dry mouth, and feelings of weakness being observed after both drugs while sweating was observed more frequently after zomepirac. The assay further provided a demonstration of the effectiveness of the twin crossover design as a clinical assay method, providing increased sensitivity of crossover data in a patient population available for only a limited number of study treatments.
 ...
PMID:Relative analgesic potency of oral zomepirac and intramuscular morphine in cancer patients with postoperative pain. 699 41

The safety and efficacy of guanabenz and clonidine were compared in 188 hypertensive patients during a 6-month double-blind trial. Mean supine diastolic blood pressure (SDBP) decreased from 103 to 88 mm Hg (p less than 0.01) among guanabenz patients and from 101 to 88 mm Hg (p less than 0.01) among clonidine patients who completed 6 months of b.i.d. therapy. Clinically significant individual SDBP decreases occurred in 85% of the guanabenz patients and 83% of the clonidine patients after 6 months. Adverse effects, consisting primarily of drowsiness, dry mouth, dizziness, and weakness, were similar in the two therapy groups. The responses obtained with guanabenz (b.i.d.) were maintained, along with a decrease in adverse effects, by an equivalent single daily dose of guanabenz during a second 6 months of therapy. Seventy-six per cent (13/17) of the patients whose blood pressure was not adequately controlled by guanabenz alone after 8 weeks of therapy subsequently responded to a combination of guanabenz and hydrochlorothiazide. Similarly, 85% (17/20) of the patients who failed to respond to clonidine alone subsequently responded to guanabenz either alone or in combination with hydrochlorothiazide. These results suggest that guanabenz or the combination of guanabenz and hydrochlorothiazide is effective therapy for the majority of hypertensive patients.
 ...
PMID:Comparative antihypertensive effects of guanabenz and clonidine. 703 2

Guanabenz, a centrally acting alpha-adrenergic antihypertensive agent, produces neither the sodium retention seen with other centrally acting agents nor the metabolic abnormalities characteristic of diuretics. In this study, which involved 204 hypertensive out-patients, the additive effects of guanabenz and hydrochlorothiazide were compared with the effects of hydrochlorothiazide therapy alone. Before randomization to the 6-month blinded addition of either guanabenz or placebo, hydrochlorothiazide (50 or 100 mg/day; mean, 70 mg/day) was administered as sole therapy for 6 weeks. During this time, mean supine diastolic blood pressure (SDBP) decreased from 102 to 94 mm Hg (p less than 0.01), with a satisfactory clinical response rate of 62% and a mean weight loss of 2 lbs (p less than 0.01). No further change in mean SDBP occurred during the next 6 months of diuretic therapy, whereas the addition of guanabenz (mean dose, 24 mg/day) caused a further decrease in mean SDBP to 88 mm Hg (p less than 0.01), an increase in the response rate to 86%, and no weight change. Pulse rates in both groups were unchanged. The principal side-effects in both groups were dry mouth, drowsiness, weakness, and dizziness, with a greater incidence of each during the combination therapy. The usual laboratory abnormalities were associated with hydrochlorothiazide. Guanabenz was found to enhance the antihypertensive efficacy of hydrochlorothiazide without compromising its natriuretic properties or producing additional metabolic abnormalities.
 ...
PMID:Evaluation of guanabenz added to hydrochlorothiazide therapy in hypertension. 704 56

In 25 patients with spasticity, pharmacokinetics and effects of dantrolene sodium were investigated after prolonged administration. A beneficial effect occurred in seven patients. The results were better on 100 mg daily than on a higher daily dose. An increase of the daily dose from 200 to 400 mg was not associated with higher blood levels. Many side effects were noted such as: anorexia, nausea, drowsiness, depression and muscle weakness. From this study we conclude that dantrolene sodium is a muscle relaxant with a weak to moderate effect in patients with spasticity; the effect at doses higher than 200 mg daily is probably poor.
 ...
PMID:The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration. 724 Nov 61

An experiment was carried out with 100 broiler birds of the Leghorn breed, aged 20 days. The birds were divided into groups and were given various amounts of methionine--0,5, 2, and 3 per cent with the basic standard mixture. The clinical signs of methionine intoxication were followed up--drowsiness, weakness in the legs, opisthotonus, and twisting of the neck (torticollis) alons with the loss of equilibrium. It was found that with birds receiving 0.5 per cent methionine with the diet the amount of vitamins A, E, and B1 in the blood serum and the liver rose considerably, while with birds given 2 and 3 per cent methionine with the feed the amount of these vitamins dropped essentially. Therepeutic treatment with 3 mg of vitamin E and vitamin B1 each in the course of 4 to 6 days yielded a good effect. An improvement of the general condition and disappearance of the most typical symptoms of methionine intoxication were recorded.
 ...
PMID:[Effect of vitamin B1 and vitamin E on methionine poisoning in broiler chickens]. 734 83


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>